An experimental drug slowed mental decline in Alzheimer's patients, but investors questioned its blockbuster potential. Doctors not involved with the study who reviewed the results said they were cautiously optimistic.
from USATODAY - News Top Stories https://ift.tt/2LoJkCS
via IFTTT
0 comments:
Post a Comment